Oncology
Robert Lindsley, MD, PHD
Associate Professor of Medicine, Harvard Medical School; Director, Edward P. Evans Center for Myelodysplastic Syndrome; Director of Clinical Genomics in Hematologic Malignancies
R. Coleman Lindsley, MD, PhD, is a medical oncologist specializing in hematologic malignancies at Dana-Farber Cancer Institute in Boston. His clinical focus encompasses leukemias, myelodysplastic syndromes (MDS), and myeloproliferative neoplasms, with particular expertise in bone marrow failure syndromes and myeloid malignancies. He treats patients with conditions such as acute myeloid leukemia, familial leukemia predisposition syndromes, and MDS, incorporating advanced genomic profiling to guid
17+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (ABIM)
Education & Training
- Washington University School of Medicine — M.D., Ph.D. (Immunology)
- Brigham and Women's Hospital — Residency, Internal Medicine
- Dana-Farber/Partners CancerCare — Fellowship, Oncology
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
17+ years in practice